vaccine has been approved for use for 12 to 15-year-olds, the Medicines and Healthcare products Regulatory Agency has announced.
The MHRA said the decision follows a "rigorous review" of safety and effectiveness in that age group.Dr June Raine, MHRA chief executive, said: "We have carefully reviewed clinical trial data in children aged 12 to 15 years and have concluded that the Pfizer/BioNTech Covid-19 vaccine is safe and effective in this age group and that the benefits of this vaccine outweigh any risk."We have in place a comprehensive safety surveillance strategy for monitoring the safety of all UK-approved Covid-19 vaccines and this surveillance will include the 12- to 15-year age group."No extension to an authorisation would be.